BCL2 and colorectal carcinoma: More importantly, YAP can inhibit autophagy and promote progression of colorectal cancer via upregulating Bcl‐2 expression, while autophagy‐related pathways are enriched and activated in CRC patients and can induce cancer chemoresistance.24, 28